2-Bromo-5-(pyrrolidin-1-YL)pyrazine
Names and Identifiers of 2-Bromo-5-(pyrrolidin-1-YL)pyrazine
CAS Number |
1001050-21-0 |
|---|---|
MDL Number |
MFCD09878938 |
IUPAC Name |
2-bromo-5-pyrrolidin-1-ylpyrazine |
InChI |
InChI=1S/C8H10BrN3/c9-7-5-11-8(6-10-7)12-3-1-2-4-12/h5-6H,1-4H2 |
InChIKey |
OJPYLBAZSVUCNX-UHFFFAOYSA-N |
Canonical SMILES |
C1CCN(C1)C2=CN=C(C=N2)Br |
UNSPSC Code |
12352100 |
Physical and chemical properties of 2-Bromo-5-(pyrrolidin-1-YL)pyrazine
Boiling Point |
331.1±42.0 °C at 760 mmHg |
|---|---|
Density |
1.6±0.1 g/cm3 |
Exact Mass |
227.005798 |
Flash Point |
154.0±27.9 °C |
Index of Refraction |
1.603 |
LogP |
2.12 |
Molecular Formula |
C8H10BrN3 |
Molecular Weight |
228.089 |
PSA |
29.02000 |
Storage condition |
2-8°C |
Vapour Pressure |
0.0±0.7 mmHg at 25°C |
Safety Information of 2-Bromo-5-(pyrrolidin-1-YL)pyrazine
Applications of 2-Bromo-5-(pyrrolidin-1-YL)pyrazine
2-Bromo-5-(pyrrolidin-1-yl)pyrazine has several applications across various fields:
- Medicinal Chemistry: It serves as a building block for synthesizing novel drug candidates with potential therapeutic effects.
- Material Science: The compound is utilized in developing materials with specific electronic properties due to its unique structure.
- Biological Research: It is employed in studies investigating biological pathways, particularly those related to neuropharmacology and cancer biology.
Interaction Studies of 2-Bromo-5-(pyrrolidin-1-YL)pyrazine
Interaction studies involving 2-Bromo-5-(pyrrolidin-1-yl)pyrazine have revealed its potential to modulate various biological pathways. For instance, it may inhibit specific enzymes or receptors that play critical roles in disease processes. Understanding these interactions is vital for elucidating its mechanism of action and potential therapeutic applications.
Biological Activity of 2-Bromo-5-(pyrrolidin-1-YL)pyrazine
Research indicates that 2-Bromo-5-(pyrrolidin-1-yl)pyrazine exhibits significant biological activity. It has been studied for its potential as a pharmacological agent, particularly in the context of enzyme inhibition and receptor binding. The compound's structure allows it to interact with various biological targets, making it a candidate for developing new therapeutic agents.
Notably, it has shown activity against certain cancer cell lines and may have implications in treating neurological disorders due to its ability to cross the blood-brain barrier.
Physical sample testing spectrum (NMR) of 2-Bromo-5-(pyrrolidin-1-YL)pyrazine
